QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations 期刊论文 EBIOMEDICINE, 2021, 卷号: 69, 页码: 11 作者:  Yang, Mei;  Fan, Yanhui;  Wu, Zhi-Yong;  Gu, Jin;  Feng, Zhendong 收藏  |  浏览/下载：44/0  |  提交时间：2021/12/01 HER2-negative breast cancer  Germline rare coding mutations  Damage assessment of genomic mutations (DAGM)  Risk assessment  Activity profiles of signalling pathways (APSP)  HER2 signalling pathway  Immune suppression   Efficacy of everolimus-containing chemotherapy in HER2 negative metastatic breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Wang, Rong;  Wang, Xiaojia;  Chen, Zhan-Hong;  Niu, Jin;  Huang, Yuan 收藏  |  浏览/下载：11/0  |  提交时间：2022/01/10 Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer 期刊论文 CANCER RESEARCH, 2021, 卷号: 81, 期号: 4, 页码: 1 作者:  Yang, Mei;  Fan, Yanhui;  Wu, Zhi-Yong;  Feng, Zhendong;  Zhang, Qiangzu 收藏  |  浏览/下载：48/0  |  提交时间：2021/12/01 The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9 作者:  Tian, Yiping;  Sun, Xiaohui;  Cheng, Guoping;  Ji, Enming;  Yang, Shifeng 收藏  |  浏览/下载：32/0  |  提交时间：2021/05/17 CMTM6  PD-L1  triple-negative breast cancer (TNBC)  immunohistochemistry (IHC)  polymerase chain reaction (PCR)  prognosis